Topics

Reevaluating the Use of Hemoglobin A 1c as a Surrogate Marker in Diabetes

20:00 EDT 14 Apr 2019 | JAMA

This Viewpoint discusses the inadequacy of hemoglobin A1c levels as a marker of effects of treatment on clinically important diabetes outcomes, and argues for replacing it with measures of treatment effects important to patients and their caregivers, such as hyperglycemia and hypoglycemia, vision deterioration, neuropathy and ulceration, diabetes distress, and treatment-related financial hardship.

Original Article: Reevaluating the Use of Hemoglobin A 1c as a Surrogate Marker in Diabetes

NEXT ARTICLE

More From BioPortfolio on "Reevaluating the Use of Hemoglobin A 1c as a Surrogate Marker in Diabetes"

Quick Search

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...